Myriad Asset Management’s KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share KAHC.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding KAHC.WS
SAMU
AFM
LP
GC
AC
GRIM
RCM
KSCM
AGC
Myriad Asset Management's KAHC.WS Position: Q1 2022 in Review
Myriad Asset Management sold out of KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share (KAHC.WS) in Q1 2022, closing a stake of 125,000 shares — an estimated $125K sold.
Myriad Asset Management first reported a position in KAHC.WS in Q3 2021 and held it in 2 quarters. The position peaked at $125K in Q4 2021. 73 funds tracked by Wall St. Rank hold KAHC.WS as of Q1 2022.
- Myriad Asset Management reported no remaining KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share position as of Q1 2022 after selling out during the quarter.
- Myriad Asset Management sold 125,000 KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share shares in Q1 2022, an estimated $125K.
- Myriad Asset Management first reported a position in KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share in Q3 2021 and held it in 2 quarters.
- Myriad Asset Management's KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share position peaked at $125K in Q4 2021.
- 73 funds tracked by Wall St. Rank held KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share as of Q1 2022.
Based on Myriad Asset Management's 13F filing for Q1 2022, filed 16 May 2022.